The Price of Life

Description

The NHS cannot afford to offer every treatment on the market, so Adam Wishart investigates how the nation chooses which patients should be the winners and which should be the losers. He focuses on the decision about one single drug, gaining unprecedented access to the National Institute for Health and Clinical Excellence - the body that decides which treatments the national budget can stretch to - as well as the cancer patients who need the life-extending treatment and the American company which will profit from the medication's use.

Tags